Share Capital - Schedule of Options Data (Details) - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
Dec. 31, 2022 |
||||
| Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] | ||||||
| Total fair value of options granted | $ 252 | $ 747 | $ 3,970 | |||
| Weighted-average grant date fair value of options granted, per option (in Dollars per share) | $ 3.33 | $ 4.73 | $ 5.32 | |||
| Total intrinsic value of the options exercised | [1] | $ 271 | $ 221 | |||
| Total fair value of options vested | $ 1,549 | $ 4,380 | $ 2,802 | |||
| ||||||
| X | ||||||||||
- Definition Represent the total fair value of options granted. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|